# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k121557   
B. Purpose for Submission: New device   
C. Measurand: Cannabinoids and Propoxyphene   
D. Type of Test: Qualitative immunochromatographic assay   
E. Applicant: Guangzhou Wondfo Biotech Co., Ltd.   
F. Proprietary and Established Names: Wondfo Cannabinoids Urine Test Wondfo Propoxyphene Urine Test   
G. Regulatory Information:

<table><tr><td rowspan=1 colspan=1>Product Code</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>Regulation Section</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>LDJ</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>862.3870 Cannabinoids test system</td><td rowspan=1 colspan=1>91, Toxicology</td></tr><tr><td rowspan=1 colspan=1>LFG</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>862.3700 Propoxyphene test system</td><td rowspan=1 colspan=1>91, Toxicology</td></tr></table>

# H. Intended Use:

1. Intended use(s): See indication for use below

2. Indication(s) for use: Wondfo Cannabinoids Urine Test

Wondfo Cannabinoids Urine Test is an immunochromatographic assay for the qualitative determination of 11-nor- $\cdot \Delta 9$ -THC-9-COOH (major metabolite of Cannabinoids) in human urine at a cutoff concentration of $5 0 ~ \mathrm { n g / m L }$ . The test is available in a dip card format and a cup format. It is intended for prescription use and over the counter use.

The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. GC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

# Wondfo Propoxyphene Urine Test

Wondfo Propoxyphene Urine Test is an immunochromatographic assay for the qualitative determination of d-Propoxyphene in human urine at a cutoff concentration of $3 0 0 ~ \mathrm { { n g / m L } }$ . The test is available in a dip card format and a cup format. It is intended for prescription use.

The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. GC/MS is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

3. Special conditions for use statement(s):

For prescription and over the counter use for Cannabinoids.

For prescription use for Propoxyphene. Propoxyphene has not been evaluated for Point-of-care use.

4. Special instrument requirements:

Not applicable, as the device is a visually-read single-use device

# I. Device Description:

The devices are for use in human urine in dip card and cup formats. The Dip Card and Cup Tests are single-test test strips. The Dip Card and Cup Tests contain test dip card or cup and package insert (instructions for use). Both devices are single-use and visually read.

# J. Substantial Equivalence Information:

1. Predicate device name(s): ACON One Step Drug Screen Test, Acon Laboratories ACON One Step Propoxyphene Test Strip and Device, Acon Laboratories

2. Predicate 510(k) number(s): k020771 and k040445 respectively

3. Comparison with predicate:

<table><tr><td rowspan=1 colspan=3>Similarities and Differences</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicates (k020771)</td></tr><tr><td rowspan=1 colspan=1>Indications for Use</td><td rowspan=1 colspan=1>For the qualitative determination ofCannabinoids in individual humanurine.</td><td rowspan=1 colspan=1>Same (different numberof drugs detected)</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Competitive binding, lateral flowimmunochromatographic assays basedon the principle of antigen-antibodyimmunochemistry</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Type of Test</td><td rowspan=1 colspan=1>Immunoassay principles that rely onantigen-antibody interactions toindicate positive or negative result</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>11-nor-Δ9-THC-9-COOH</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Specimen Type</td><td rowspan=1 colspan=1>Human Urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Cut Off Value</td><td rowspan=1 colspan=1>Cannabinoids: 50 ng/ml</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Configurations</td><td rowspan=1 colspan=1>Cup, Dip Card</td><td rowspan=1 colspan=1>Card, dip card withintegrated cup (same)</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>OTC Use &amp; Prescription Use</td><td rowspan=1 colspan=1>Prescription Use</td></tr></table>

<table><tr><td colspan="3" rowspan="1">Similarities and Differences</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Device</td><td colspan="1" rowspan="1">Predicates (k040445)</td></tr><tr><td colspan="1" rowspan="1">Indications for Use</td><td colspan="1" rowspan="1">For the qualitative determination ofPropoxyphene in individual humanurine.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Methodology</td><td colspan="1" rowspan="1">Competitive binding, lateral flowimmunochromatographic assays basedon the principle of antigen-antibodyimmunochemistry</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Type of Test</td><td colspan="1" rowspan="1">Immunoassay principles that rely onantigen-antibody interactions toindicate positive or negative result</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Calibrator</td><td colspan="1" rowspan="1">d-Propoxyphene</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Specimen Type</td><td colspan="1" rowspan="1">Human Urine</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Cut Off Value</td><td colspan="1" rowspan="1">Propoxyphene 300 ng/mL</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Configurations</td><td colspan="1" rowspan="1">Cup, Dip Card</td><td colspan="1" rowspan="1">Strip, device</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">Prescription Use</td><td colspan="1" rowspan="1">Prescription Use</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

None were referenced

# L. Test Principle:

The Wondfo Cannabinoids Urine Test and Wondfo Propoxyphene Urine Test are immunochromatographic assay for Cannabinoids and Propoxyphene Urine test using a lateral flow, one step system for the qualitative detection of 11-nor- $. \Delta 9$ -THC-9- COOH and d-Propoxyphene in human urine. Each assay uses a mouse monoclonal antibody-dye conjugate against drug with gold chloride and fixed drug-protein conjugate and anti-mouse IgG polycolonal antibody in membrane.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility:

Precision studies were performed using drug free urine spiked to the following concentrations: 0 $\% + 1 0 0 \%$ , $+ / - 7 5 \%$ of cutoff, $+ / - 5 0 \%$ of cutoff, $+ / - 2 5 \%$ of cutoff for each analyte and each device. The samples were aliquots, coded, randomized and blinded. Testing was performed twice a day for twenty-five days by three operators. Three different lot numbers for each device were used for the study. A total of 50 determinations were made at each concentration and each lot. Sample concentrations were confirmed by GC/MS. The results are displayed in the tables below:

# Cannabinoids

<table><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Concentration ofsample ng/mL</td><td colspan="1" rowspan="1">Number ofdeterminations</td><td colspan="1" rowspan="1">Dip Card Results#Neg/#Pos</td><td colspan="1" rowspan="1">Cup Results#Neg/#Pos</td></tr><tr><td colspan="1" rowspan="9">Lot 1</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50/0</td><td colspan="1" rowspan="1">50/0</td></tr><tr><td colspan="1" rowspan="1">-75%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50/0</td><td colspan="1" rowspan="1">50/0</td></tr><tr><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50/0</td><td colspan="1" rowspan="1">50/0</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50/0</td><td colspan="1" rowspan="1">50/0</td></tr><tr><td colspan="1" rowspan="1">cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">5/45</td><td colspan="1" rowspan="1">4/46</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0/50</td><td colspan="1" rowspan="1">0/50</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0/50</td><td colspan="1" rowspan="1">0/50</td></tr><tr><td colspan="1" rowspan="1">+75%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0/50</td><td colspan="1" rowspan="1">0/50</td></tr><tr><td colspan="1" rowspan="1">+100%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0/50</td><td colspan="1" rowspan="1">0/50</td></tr><tr><td colspan="1" rowspan="1">Lot 2</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50/0</td><td colspan="1" rowspan="1">50/0</td></tr><tr><td colspan="1" rowspan="8"></td><td colspan="1" rowspan="1">-75%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50/0</td><td colspan="1" rowspan="1">50/0</td></tr><tr><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50/0</td><td colspan="1" rowspan="1">50/0</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50/0</td><td colspan="1" rowspan="1">50/0</td></tr><tr><td colspan="1" rowspan="1">cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">6/44</td><td colspan="1" rowspan="1">4/46</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0/50</td><td colspan="1" rowspan="1">0/50</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0/50</td><td colspan="1" rowspan="1">0/50</td></tr><tr><td colspan="1" rowspan="1">+75%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0/50</td><td colspan="1" rowspan="1">0/50</td></tr><tr><td colspan="1" rowspan="1">+100%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0/50</td><td colspan="1" rowspan="1">0/50</td></tr><tr><td colspan="1" rowspan="9">Lot 3</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50/0</td><td colspan="1" rowspan="1">50/0</td></tr><tr><td colspan="1" rowspan="1">-75%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50/0</td><td colspan="1" rowspan="1">50/0</td></tr><tr><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50/0</td><td colspan="1" rowspan="1">50/0</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">50/0</td><td colspan="1" rowspan="1">50/0</td></tr><tr><td colspan="1" rowspan="1">cutoff</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">5/45</td><td colspan="1" rowspan="1">5/45</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0/50</td><td colspan="1" rowspan="1">0/50</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0/50</td><td colspan="1" rowspan="1">0/50</td></tr><tr><td colspan="1" rowspan="1">+75%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0/50</td><td colspan="1" rowspan="1">0/50</td></tr><tr><td colspan="1" rowspan="1">+100%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0/50</td><td colspan="1" rowspan="1">0/50</td></tr></table>

Propoxyphene   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Concentration ofsample ng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Dip Card Results#Neg/#Pos</td><td rowspan=1 colspan=1>Cup Results#Neg/#Pos</td></tr><tr><td rowspan=9 colspan=1>Lot 1</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>6/44</td><td rowspan=1 colspan=1>5/45</td></tr><tr><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=9 colspan=1>Lot 2</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>5/45</td><td rowspan=1 colspan=1>4/46</td></tr><tr><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=9 colspan=1>Lot 3</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>50/0</td><td rowspan=1 colspan=1>50/0</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>4/46</td><td rowspan=1 colspan=1>7/43</td></tr><tr><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr><tr><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0/50</td><td rowspan=1 colspan=1>0/50</td></tr></table>

$b$ . Linearity/assay reportable range:

Not applicable, the devices are intended for qualitative use.

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

External control standards are not supplied with this device; however, this device has internal process controls. A colored line appearing in the control region confirms sufficient sample volume and adequate membrane wicking. Users are informed that the test is invalid if a line fails to appear in the control region.

Stability

Accelerated and real time studies have been conducted. Protocols and acceptance criteria were described and found to be acceptable. The manufacturer claims the following expiration date: The Wondfo Cannabinoids Urine Test and Wondfo Propoxyphene Urine Test unopened stability is 18 months for both formats (cup and dip card) when stored at $4 { - } 3 0 ^ { \circ } \mathrm { C }$ .

d. Detection limit:

Analytical performance of the device around the cutoff is described in Section f.   
(Assay cut-off) below.

# e. Analytical specificity:

Cross-reactivity was established by spiking similarly structured compounds into drug free urine at various concentrations. These solutions were tested using 3 lots/device (dip card and cup). Results are expressed as a minimum concentration of metabolite or compound required to produce a response approximately equivalent to the cutoff concentration of the assay. Both devices produced similar results. The percent cross-reactivity of those compounds are presented below:

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Tested Concentration(ng/mL)</td><td rowspan=1 colspan=1>% Cross-reactivity</td></tr><tr><td rowspan=1 colspan=1>THC (Cannabinoids) 11-nor-Δ9-THC-9-COOH</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>11-nor-Δ8-THC-9-COOH</td><td rowspan=1 colspan=1>30</td><td rowspan=1 colspan=1>167%</td></tr><tr><td rowspan=1 colspan=1>11-hydroxy-∆9-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>2500</td><td rowspan=1 colspan=1>2%</td></tr><tr><td rowspan=1 colspan=1>Δ8-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>7500</td><td rowspan=1 colspan=1>&lt;1%</td></tr><tr><td rowspan=1 colspan=1>Δ9-Tetrahydrocannabinol</td><td rowspan=1 colspan=1>10000</td><td rowspan=1 colspan=1>&lt;1%</td></tr><tr><td rowspan=1 colspan=1>Cannabinol</td><td rowspan=1 colspan=1>100000</td><td rowspan=1 colspan=1>&lt;1%</td></tr><tr><td rowspan=1 colspan=1>Cannabidiol</td><td rowspan=1 colspan=1>100000</td><td rowspan=1 colspan=1>&lt;1%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Tested Concentration(ng/mL)</td><td rowspan=1 colspan=1>% Cross-reactivity</td></tr><tr><td rowspan=1 colspan=1>d-Propoxyphene</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>d-Norpropoxyphene</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>100%</td></tr></table>

Structurally un-related and interference   
The following unrelated compounds were found not to cross-react when tested spiked $( 1 0 0 ~ \mu \mathrm { g / m L } )$ into urine spiked with $\pm 2 5 \%$ of the cut-off concentration of cannabinoids individually:

4-Acetamidphenol, Acetophenetidin, N-acetylprocainamide, Acetylsalicylic acid, Aminopyrine, Amitryptyline, Amobarbital, Amoxicillin, Ampicillin,

Ascorbic Acid, D,L- Amphetamine, L-Amphetamine, Apomorphine, Aspartame, Atropine, Benzilic acid, Benzoic acid, Benzoylecgonine, Benzphetamine, Bilirubin, Brompheniramine, Caffeine, Chloralhydrate, Chloramphenicol, Chlordiazepoxide, Chlorothiazide, $( \pm )$ Chlolrpheniramine, Chlorpromazine, Chlorquine, Cholesterol, Clomipramine, Clonidine, Cocaine hydrochloride, Codeine, Cortisone, (-) Cotinine, Creatinine, Deoxycorticosterone, Dextromethorphan, Diazepam, Diclofenac, Diflunisal, Digoxin, Diphenhydramine, Doxylamine, Ecgonine hydrochloride, Ecgonine methylester, (-) Y Ephedrine, Erythromycin, $\beta$ -Estradiol, Estrone-3-sulfate, Ethyl- $\boldsymbol { \cdot } \boldsymbol { \mathrm { p } }$ -aminobenzoate, Fenoprofen, Furosemide, Gentisic acid, Hemoglobin, Hydralazine, Hydrochlorothiazide, Hydrocodone, Hydrocortisone, OHydroxyhippuric, 3-Hydroxytyramine, Ibuprofen, Imipramine, Iproniazid, $( + / - )$ Isoproterenol, Isoxsuprine, Ketamine, Ketoprofen, Labetalol, Levorphanol, Loperamide, Maprotiline, Meprobamate, Methadone, Methoxyphenamine, $( + )$ 3,4 Methylenedioxyamphetamine, $( + ) 3 { , } 4$ Methylenedioxy methamphetamine, Methylphenidate, Methyprylon, Morphine-3- $\beta$ -D glucuronide, Nalorphine, Naloxone, Nalidixic Acid, Naltrexone, Naproxen, Niacinamide, Nifedipine, Norcodein, Norethindrone, D –Norpropoxphene, Noscapine, D,L- Octopamine, Oxalic Acid, Oxazepam, Oxolinic acid, Oxycodone, Oxymetazoline, $\mathfrak { p }$ -Hydroxymethamphetamine, Papaverine, Penicillin-G, Pentazocine, Pentobarbital, Perphenazine, Phencyclidine, Phenelzine, Phenobarbital, Phentermine, L-Phenylephrine, $\beta$ - Phenylethlamine, $\beta$ -Phenyllethylamine, Phenylopropanolamine, Prednisolone, Prednisone, Procaine, Promazine, Promethazine, D,L- Propranolol, DPropoxphene, D-Pseudophedrine, Quinidine, Quinine, Ranitidine Salicylic Acid, Secobarbital, Serotonin (5-Hydroxytyramine), Sulfamethazine, Sulindac, Temazepam, Tetracycline, Tetrahydrocortisone, 3 acetate, Tetrahydrocortisone3 (5 -Dglucuronide), Tetrahydozoline, Thebaine, Thiamine, Thioridazine, D, L-Thyroxine, Tolbutamide, Triamterene, Trifluoperazine, Trimethoprim, Trimipramine, Tryptamine, D,L-Tryptophan, Tyamine, PrD, L-Tyrosine, Uric Acid, Verapamil, Zomepirac

The following unrelated compounds were found not to cross-react when tested spiked $( 1 0 0 ~ \mu \mathrm { g / m L } )$ into urine spiked with $\pm 2 5 \%$ of the cut-off concentration of propoxyphene individually:

Acetophenetidin, Acetylsalicylic acid, Aminopyrine, Amoxicillin, Ampicillin, Apomorphine, Aspartame, Atropine, Benzilic acid, Benzoic acid, Benzphetamine, Bilirubin, Caffeine, Chloralhydrate, Chloramphenicol, Chlorothiazide, D,L-Chlolrpheniramine, Chlorpromazine, Chlorquine, Cholesterol, Clonidine, L- Cotinine, Cortisone, Creatinine, DPseudoephedrine, Dextromethorphan, $\beta$ -Dglucuronide, Diclofenac, Diflunisal, Digoxin, Diphenhydramine, Ecgonine methylester, L- Ephedrine, Erythromycin, $\beta$ -Estradiol, Estrone-3-sulfate, Ethyl-p-aminobenzoate, Fenoprofen, Furosemide, Gentisic acid, Hemoglobin, Hydralazine,

Hydrochlorothiazide, Hydrocortisone, O-Hydroxyhippuric, 3- Hydroxytyramine, IsoxsuprineD, L- Isoproterenol, Ketoprofen, Labetalol, Loperamide, Meprobamate, Methoxyphenamine, Morphine-3- $\beta$ -Dglucuronide, Naloxone, Nalidixic Acid, Naltrexone, Naproxen, Niacinamide, Nifedipine, Norethindrone, , Noscapine, D,L- Octopamine, Oxalic Acid, Oxolinic acid, Oxymetazoline, Papaverine, Penicillin-G, Perphenazine, Phenelzine, L-Phenylephrine, $\beta$ -Phenylethlamine, Phenylopropanolamine, , Prednisone, D,L- Propranolol, Quinidine, Quinine, Ranitidine Salicylic Acid, Serotonin, Sulfamethazine, Sulindac, Tetracycline, Tetrahydrocortisone, Tetrahydozoline, Thiamine, Thioridazine, D, L-Thyrosine, Tolbutamide, Triamterene, Trifluoperazine, Trimethoprim, D,L-Tryptophan, Tyamine, Uric Acid, Verapamil, Zomepirac

Evaluation of SG and $\mathsf { p H }$ on test results:

To evaluate the effect of pH value on the test results, a negative urine sample were adjusted to pH levels 4.0, 5.0, 6.0, 7.0, 8.0 and 9.0.The samples were then spiked with each drug at $+ / - 2 5 \%$ of the cutoff values. Testing was performed on 3 lots/device (dip card and cup).

To evaluate the effect of specific gravity, 12 urine samples having specific gravities of 1.000, 1.003, 1.007, 1.008, 1.017, 1.019, 1.020, 1.025, and 1.030, 1.031, 1.033 and 1.035 were spiked with each drug at $+ / - 2 5 \%$ of the cut-off values. Testing was performed on 3 lots/device (dip card and cup).

The testing results demonstrate that varying pHs and specific gravities do not affect urine testing results around each analyte cut-off.

# f. Assay cut-off:

Cutoff studies were performed for cannabinoids and propoxyphene using a combination of clinical and spiked samples for each drug $( \mathrm { n } { = } 1 5 0$ per drug). The testing protocol was identical for each drug.

25 clinical samples were collected for each drug. Concentrations of cannabinoids and propoxyphene in the samples were determined by GC/MS.

An additional 125 drug free negative samples were obtained for each drug and spiked with either cannabinoids and propoxyphene at $- 5 0 \%$ cutoff, $- 2 5 \%$ cutoff, cutoff, $+ 2 5 \%$ cutoff, and $+ 5 0 \%$ cutoff. 5 clinical samples and 25 spiked samples were tested at each concentration for each drug in replicates of 30 using three lots and 3 operators $\mathrm { ( n { = } 2 7 0 }$ ). Results are summarized below:

Cannabinoids   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Concentrationof sampleng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Dip CardResults#Neg/#Pos</td><td rowspan=1 colspan=1>Cup Results#Neg/#Pos</td></tr><tr><td rowspan=5 colspan=1>Lot 1</td><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>9/81</td><td rowspan=1 colspan=1>11/79</td></tr><tr><td rowspan=1 colspan=1>+25%cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td><td rowspan=1 colspan=1>0/90</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td><td rowspan=1 colspan=1>0/90</td></tr><tr><td rowspan=5 colspan=1>Lot 2</td><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>12/78</td><td rowspan=1 colspan=1>10/80</td></tr><tr><td rowspan=1 colspan=1>+25%cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td><td rowspan=1 colspan=1>0/90</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td><td rowspan=1 colspan=1>0/90</td></tr><tr><td rowspan=5 colspan=1>Lot 3</td><td rowspan=1 colspan=1>-50%cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>11/79</td><td rowspan=1 colspan=1>8/82</td></tr><tr><td rowspan=1 colspan=1>+25%cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td><td rowspan=1 colspan=1>0/90</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

Propoxyphene   

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Concentrationof sampleng/mL</td><td rowspan=1 colspan=1>Number ofdeterminations</td><td rowspan=1 colspan=1>Dip CardResults#Neg/#Pos</td><td rowspan=1 colspan=1>Cup Results#Neg/#Pos</td></tr><tr><td rowspan=5 colspan=1>Lot 1</td><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>10/80</td><td rowspan=1 colspan=1>9/81</td></tr><tr><td rowspan=1 colspan=1>+25%cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td><td rowspan=1 colspan=1>0/90</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td><td rowspan=1 colspan=1>0/90</td></tr><tr><td rowspan=5 colspan=1>Lot 2</td><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>8/82</td><td rowspan=1 colspan=1>10/80</td></tr><tr><td rowspan=1 colspan=1>+25%cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td><td rowspan=1 colspan=1>0/90</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td><td rowspan=1 colspan=1>0/90</td></tr><tr><td rowspan=5 colspan=1>Lot 3</td><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>90/0</td><td rowspan=1 colspan=1>90/0</td></tr><tr><td rowspan=1 colspan=1>Cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>9/81</td><td rowspan=1 colspan=1>10/80</td></tr><tr><td rowspan=1 colspan=1>+25%cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td><td rowspan=1 colspan=1>0/90</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>90</td><td rowspan=1 colspan=1>0/90</td><td rowspan=1 colspan=1>0/90</td></tr></table>

2. Comparison studies:

a. Method comparison with predicate device: The method comparison for the Wondfo Cannabinoids Urine Test and Wondfo Propoxyphene Urine Test was performed in-house with three laboratory assistants with relevant experience and a lay person with no experience other than reading the instructions for use. Operators ran 80 (40 negative and 40 positive) unaltered clinical samples. The samples were blind labeled and compared to GC/MS results. The results are presented in the table below:

Cannabinoids   

<table><tr><td rowspan=1 colspan=1>Cupformat</td><td rowspan=1 colspan=1>−</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than -50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byC/MS(Between -50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>LayPerson</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Cannabinoids   

<table><tr><td rowspan=1 colspan=1>DipCardformat</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than -50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byC/MS(Between -50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>LayPerson</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant table:   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample number</td><td rowspan=1 colspan=1>GC/MS result</td><td rowspan=1 colspan=1>Cup formatViewer result</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>GDA 19</td><td rowspan=1 colspan=1>47</td><td rowspan=1 colspan=1>positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>GDA 20</td><td rowspan=1 colspan=1>49</td><td rowspan=1 colspan=1>positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>GDA 20</td><td rowspan=1 colspan=1>49</td><td rowspan=1 colspan=1>positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>GDA 19</td><td rowspan=1 colspan=1>47</td><td rowspan=1 colspan=1>positive</td></tr><tr><td rowspan=1 colspan=1>Lay person</td><td rowspan=1 colspan=1>GDA 19</td><td rowspan=1 colspan=1>47</td><td rowspan=1 colspan=1>positive</td></tr><tr><td rowspan=1 colspan=1>Lay person</td><td rowspan=1 colspan=1>GDA 20</td><td rowspan=1 colspan=1>49</td><td rowspan=1 colspan=1>positive</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample number</td><td rowspan=1 colspan=1>GC/MS result</td><td rowspan=1 colspan=1>Dip Cardformat viewerresults</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>GDA 20</td><td rowspan=1 colspan=1>49</td><td rowspan=1 colspan=1>positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>GDA 19</td><td rowspan=1 colspan=1>47</td><td rowspan=1 colspan=1>positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>GDA 19</td><td rowspan=1 colspan=1>47</td><td rowspan=1 colspan=1>positive</td></tr><tr><td rowspan=1 colspan=1>Lay person</td><td rowspan=1 colspan=1>GDA 20</td><td rowspan=1 colspan=1>49</td><td rowspan=1 colspan=1>positive</td></tr></table>

Propoxyphene   

<table><tr><td rowspan=1 colspan=1>Cupformat</td><td rowspan=1 colspan=1>−</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than -50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byC/MS(Between -50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Propoxyphene   

<table><tr><td rowspan=1 colspan=1>DipCardformat</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byC/MS(less than -50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between -50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>25</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant result   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample number</td><td rowspan=1 colspan=1>GC/MS result</td><td rowspan=1 colspan=1>Cup formatViewer result</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PPX317</td><td rowspan=1 colspan=1>297.4</td><td rowspan=1 colspan=1>positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>PPX63</td><td rowspan=1 colspan=1>295.6</td><td rowspan=1 colspan=1>positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>PPX318</td><td rowspan=1 colspan=1>293.8</td><td rowspan=1 colspan=1>positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>PPX63</td><td rowspan=1 colspan=1>295.6</td><td rowspan=1 colspan=1>positive</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample number</td><td rowspan=1 colspan=1>GC/MS result</td><td rowspan=1 colspan=1>Dip Cardformat viewerresults</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PPX318</td><td rowspan=1 colspan=1>293.8</td><td rowspan=1 colspan=1>positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>PPX317</td><td rowspan=1 colspan=1>297.4</td><td rowspan=1 colspan=1>positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>PPX317</td><td rowspan=1 colspan=1>297.4</td><td rowspan=1 colspan=1>positive</td></tr></table>

Lay-user study for Cannabinoids

Test Cup format:

A lay user study was performed at three intended user sites with 140 lay persons.

Participants in the study were 66 females and 74 males tested the cannabinoids samples. They had diverse educational and professional backgrounds and ranged in age from 21 to ${ > } 5 0$ . Urine samples were prepared at the following concentrations; negative, $+ / - 7 5 \%$ , $+ / .$ - $50 \%$ , $+ / - 2 5 \%$ of the cutoff by spiking drug(s) into drug free-pooled urine specimens. The concentrations of the samples were confirmed by GC/MS. Each sample was aliquoted into individual containers and blind-labeled. Each participant was provided with the package insert, 1 blind labeled samples and a device. The results are summarized below.

<table><tr><td rowspan=1 colspan=2>Cup format</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=1 colspan=2>OTC user</td><td rowspan=2 colspan=1>%AgreementWithGC/MS</td></tr><tr><td rowspan=1 colspan=1>Drug</td><td rowspan=1 colspan=1>Concentration</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=7 colspan=1>Cannabinoids</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>85%</td></tr><tr><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>90%</td></tr><tr><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr></table>

Dip Card format:

A lay user study was performed at three intended user sites with 140 lay persons.

Participants in the study were 63 females and 77 males tested the cannabinoids samples. They had diverse educational and professional backgrounds and ranged in age from 21 to ${ > } 5 0$ . Urine samples were prepared at the following concentrations; negative, $+ / - 7 5 \%$ , $+ / .$ - $50 \%$ , $+ / - 2 5 \%$ of the cutoff by spiking drug(s) into drug free-pooled urine specimens. The concentrations of the samples were confirmed by GC/MS. Each sample was aliquoted into individual containers and blind-labeled. Each participant was provided with the package insert, 1 blind labeled samples and a device. The results are summarized below.

<table><tr><td rowspan=1 colspan=2>Dip Card format</td><td rowspan=2 colspan=1>Number ofsamples</td><td rowspan=1 colspan=2>OTC user</td><td rowspan=2 colspan=1>%AgreementWithGC/MS</td></tr><tr><td rowspan=1 colspan=1>Drug</td><td rowspan=1 colspan=1>Concentration</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=7 colspan=1>Cannabinoids</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>85%</td></tr><tr><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>95%</td></tr><tr><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100%</td></tr></table>

All study participants completed questionnaires after the performed the test and recorded their results. The questionnaires covered evaluation of the package insert regarding expiration date of the device, storage, the directions for performing the test, the ease of performing the test, directions for interpreting the results, and ease of interpretation of the results. These questionnaires demonstrated that the test instructions were easy to understand and that the testing procedure was easy to perform and the results were easy to read.

b. Matrix comparison: Not applicable

3. Clinical studies:

a. Clinical Sensitivity: Not applicable   
b. Clinical specificity: Not applicable   
c. Other clinical supportive data (when a. and b. are not applicable): Not applicable

4. Clinical cut-off: Not applicable

5. Expected values/Reference range: Not applicable

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.